Advertisement
Screener

BRISTOL-MYERS SQUIBB COMPANY (BMY) Other Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31)

2.2 / 5 stars · 48/110 Roast Me

BRISTOL-MYERS SQUIBB COMPANY Other Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31)

BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Other Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) of -$1.00 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-25.

Discontinued › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesTax · last filed 2012-07-25

  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $0.00.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was -$1.00M, a 120.00% decline year-over-year.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$1.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for the quarter ending 2011-09-30 was -$3.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for fiscal 2011 was -$7.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for fiscal 2010 was -$3.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for fiscal 2009 was -$4.00M.
  • BRISTOL-MYERS SQUIBB COMPANY other comprehensive income (loss), available-for-sale securities, tax (deprecated 2012-01-31) for fiscal 2008 was $0.00, a 100.00% decline from fiscal 2007.
Period endOther Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 3 monthOther Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 3 month as first filedOther Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 6 monthOther Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 6 month as first filedOther Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 9 monthOther Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 9 month as first filedOther Comprehensive Income (Loss), Available-for-sale Securities, Tax (Deprecated 2012-01-31) 12 month
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25
-$1.00M
10-Q · filed 2012-07-25
-$2.00M
derived: sum of 3 quarters · filed 2012-07-25
-$5.00M
derived: sum of 4 quarters · filed 2012-07-25
2012-03-31-$1.00M
10-Q · filed 2012-04-26
-$2.00M
derived: sum of 2 quarters · filed 2012-04-26
-$5.00M
derived: sum of 3 quarters · filed 2012-04-26
-$13.00M
derived: sum of 4 quarters · filed 2012-07-25
2011-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17
-$4.00M
derived: sum of 2 quarters · filed 2012-02-17
-$12.00M
derived: sum of 3 quarters · filed 2012-07-25
-$7.00M
10-K · filed 2012-02-17
2011-09-30-$3.00M
10-Q · filed 2011-10-27
-$11.00M
derived: sum of 2 quarters · filed 2012-07-25
-$6.00M
10-Q · filed 2011-10-27
-$8.00M
derived: sum of 4 quarters · filed 2012-07-25
2011-06-30-$8.00M
10-Q · filed 2012-07-25
-$3.00M
10-Q · filed 2012-07-25
-$5.00M
derived: sum of 3 quarters · filed 2012-07-25
-$5.00M
derived: sum of 4 quarters · filed 2012-07-25
2011-03-31$5.00M
10-Q · filed 2012-04-26
$3.00M
derived: sum of 2 quarters · filed 2012-04-26
$3.00M
derived: sum of 3 quarters · filed 2012-04-26
$1.00M
derived: sum of 4 quarters · filed 2012-04-26
2010-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17
-$2.00M
derived: sum of 2 quarters · filed 2012-02-17
-$4.00M
derived: sum of 3 quarters · filed 2012-02-17
-$3.00M
10-K · filed 2012-02-17
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27
-$2.00M
derived: sum of 2 quarters · filed 2011-10-27
-$1.00M
10-Q · filed 2011-10-27
-$4.00M
derived: sum of 4 quarters · filed 2012-02-17
2010-06-30-$2.00M
10-Q · filed 2011-07-28
-$1.00M
10-Q · filed 2011-07-28
-$4.00M
derived: sum of 3 quarters · filed 2012-02-17
-$6.00M
derived: sum of 4 quarters · filed 2012-02-17
2010-03-31-$1.00M
10-Q · filed 2011-04-28
-$2.00M
derived: sum of 2 quarters · filed 2012-02-17
-$4.00M
derived: sum of 3 quarters · filed 2012-02-17
-$8.00M
derived: sum of 4 quarters · filed 2012-02-17
2009-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17
-$3.00M
derived: sum of 2 quarters · filed 2012-02-17
-$7.00M
derived: sum of 3 quarters · filed 2012-02-17
-$4.00M
10-K · filed 2012-02-17
2009-09-30-$2.00M
10-Q · filed 2010-10-26
$2.00M
10-Q · filed 2009-10-22
-$6.00M
derived: sum of 2 quarters · filed 2010-10-26
-$3.00M
10-Q · filed 2010-10-26
$3.00M
10-Q · filed 2009-10-22
-$12.00M
derived: sum of 4 quarters · filed 2011-02-18
2009-06-30-$4.00M
10-Q · filed 2010-07-22
$4.00M
10-Q · filed 2009-07-23
-$5.00M
10-Q · filed 2010-07-22
$5.00M
10-Q · filed 2009-07-23
-$10.00M
derived: sum of 3 quarters · filed 2011-02-18
-$5.00M
derived: sum of 4 quarters · filed 2011-02-18
2009-03-31-$1.00M
10-Q · filed 2010-04-29
-$6.00M
derived: sum of 2 quarters · filed 2011-02-18
-$1.00M
derived: sum of 3 quarters · filed 2011-02-18
$2.00M
derived: sum of 4 quarters · filed 2011-02-18
2008-12-31-$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18
$0.00
derived: sum of 2 quarters · filed 2011-02-18
$3.00M
derived: sum of 3 quarters · filed 2011-02-18
$0.00
10-K · filed 2011-02-18
2008-09-30$5.00M
10-Q · filed 2009-10-22
$8.00M
derived: sum of 2 quarters · filed 2009-10-22
$5.00M
10-Q · filed 2009-10-22
2008-06-30$3.00M
10-Q · filed 2009-07-23
$1.00M
10-Q · filed 2009-07-23
2007-12-31$19.00M
10-K · filed 2010-02-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
PFIZER INC (PFE)United States$162.042B31.94
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64